Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention. Rincones A, Fitzsimmons M, Kolli A, Brugal L C, Robertson DS, Ciotti JR Int J MS Care. 2025; 27(4):304-311. PMID: 42903011. Abstract CommentRecommendBookmarkWatch
